Literature DB >> 19609939

TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment.

Sandra Isenmann1, Agnieszka Arthur, Andrew C W Zannettino, Jenna L Turner, Songtao Shi, Carlotta A Glackin, Stan Gronthos.   

Abstract

The TWIST family of basic helix-loop-helix transcription factors, Twist-1 and Dermo-1 are known mediators of mesodermal tissue development and contribute to correct patterning of the skeleton. In this study, we demonstrate that freshly purified human bone marrow-derived mesenchymal stromal/stem cells (MSC) express high levels of Twist-1 and Dermo-1 which are downregulated following ex vivo expansion. Enforced expression of Twist-1 or Dermo-1 in human MSC cultures increased expression of the MSC marker, STRO-1, and the early osteogenic transcription factors, Runx2 and Msx2. Conversely, overexpression of Twist-1 and Dermo-1 was associated with a decrease in the gene expression of osteoblast-associated markers, bone morphogenic protein-2, bone sialoprotein, osteopontin, alkaline phosphatase and osteocalcin. High expressing Twist-1 or Dermo-1 MSC lines exhibited an enhanced proliferative potential of approximately 2.5-fold compared with control MSC populations that were associated with elevated levels of Id-1 and Id-2 gene expression. Functional studies demonstrated that high expressing Twist-1 and Dermo-1 MSC displayed a decreased capacity for osteo/chondrogenic differentiation and an enhanced capacity to undergo adipogenesis. These findings implicate the TWIST gene family members as potential mediators of MSC self-renewal and lineage commitment in postnatal skeletal tissues by exerting their effects on genes involved in the early stages of bone development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609939     DOI: 10.1002/stem.181

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  79 in total

Review 1.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

2.  Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines.

Authors:  Kim Hynes; Danijela Menicanin; Krzysztof Mrozik; Stan Gronthos; P Mark Bartold
Journal:  Stem Cells Dev       Date:  2014-02-07       Impact factor: 3.272

Review 3.  Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts.

Authors:  Maya Fakhry; Eva Hamade; Bassam Badran; René Buchet; David Magne
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

4.  Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels.

Authors:  Wen-Tzu Lai; Veena Krishnappa; Donald G Phinney
Journal:  Stem Cells       Date:  2011-07       Impact factor: 6.277

5.  Isolation of murine bone marrow derived mesenchymal stem cells using Twist2 Cre transgenic mice.

Authors:  Yaling Liu; Liping Wang; Reza Fatahi; Mark Kronenberg; Ivo Kalajzic; David Rowe; Yingcui Li; Peter Maye
Journal:  Bone       Date:  2010-07-27       Impact factor: 4.398

6.  Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele.

Authors:  Aijun Wang; Erin G Brown; Lee Lankford; Benjamin A Keller; Christopher D Pivetti; Nicole A Sitkin; Michael S Beattie; Jacqueline C Bresnahan; Diana L Farmer
Journal:  Stem Cells Transl Med       Date:  2015-04-24       Impact factor: 6.940

7.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma.

Authors:  Svetlana A Mikheeva; Andrei M Mikheev; Audrey Petit; Richard Beyer; Robert G Oxford; Leila Khorasani; John-Patrick Maxwell; Carlotta A Glackin; Hiroaki Wakimoto; Inés González-Herrero; Isidro Sánchez-García; John R Silber; Philip J Horner; Robert C Rostomily
Journal:  Mol Cancer       Date:  2010-07-20       Impact factor: 27.401

8.  Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.

Authors:  Zhifang Zhang; John E Shively
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

Review 9.  Transcriptional regulatory cascades in Runx2-dependent bone development.

Authors:  Tong Ming Liu; Eng Hin Lee
Journal:  Tissue Eng Part B Rev       Date:  2012-12-28       Impact factor: 6.389

10.  A possible inflammatory role of twist1 in human white adipocytes.

Authors:  Amanda T Pettersson; Jurga Laurencikiene; Niklas Mejhert; Erik Näslund; Anne Bouloumié; Ingrid Dahlman; Peter Arner; Mikael Rydén
Journal:  Diabetes       Date:  2009-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.